Bosco, Giosiana
Mszar, Reed
Piro, Salvatore
Sabouret, Pierre
Gallo, Antonio
Article History
Accepted: 17 June 2024
First Online: 5 July 2024
Declarations
:
: The authors declare no competing interests.
: GB declares not to have conflict of interest. AG reports grants and personal fees from AMGEN, grants and personal fees from SANOFI, personal fees from VIATRIS, personal fees from AMARIN, personal fees from ULTRAGENYX, personal fees from SERVIER, personal fees from MSD, personal fees from AKCEA THERAPEUTICS, personal fees from AMRYT, personal fees from NOVARTIS, outside the submitted work. Ps declares that he has received speaker fees from Astra Zeneca, Axis TV, BMS, Les laboratoires Servier, Novartis, Novo Nordisk, Sanofi outside the present work. SP has nothing to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.